Annovis Bio ANVS
NYSE ANVS
$1.82 +0.03 (+1.68%)
At close: Aug 21, 2026 · 4:00 PM EDT

Annovis Bio (ANVS) Shares Outstanding (Entity) (2019 - 2026)

Annovis Bio (ANVS) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Annovis Bio 67.91 Mn 67.91 Mn - 42.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.54 Mn
Dec 31, 2025 20.55 Mn
Sep 30, 2025 20.19 Mn
Jun 30, 2025 19.49 Mn
Mar 31, 2025 19.49 Mn
Dec 31, 2024 14.14 Mn
Sep 30, 2024 13.28 Mn
Jun 30, 2024 11.72 Mn
Mar 31, 2024 11.01 Mn
Dec 31, 2023 10.52 Mn
Sep 30, 2023 9.01 Mn
Jun 30, 2023 9.01 Mn
Mar 31, 2023 8.22 Mn
Dec 31, 2022 8.16 Mn
Sep 30, 2022 8.16 Mn
Jun 30, 2022 8.16 Mn
Mar 31, 2022 8.16 Mn
Dec 31, 2021 8.10 Mn
Sep 30, 2021 8.10 Mn
Jun 30, 2021 8.09 Mn